Officer and Director of Alpharma Inc., a public human and animal specialty pharmaceutical company, which was acquired by King Pharmaceuticals in December 2008. Prior to Alpharma, Mr. Mitchell was President and CEO of Guilford Pharmaceuticals, a publicly...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Lux Biosciences Names Dean Mitchell President and CEO
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account